MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202531129025 A) filed by Kalinga Institute Of Industrial Technology, Bhubaneswar, Orissa, on Dec. 19, 2025, for 'olanzapine matrix transdermal patch.'
Inventor(s) include Bose, Tithi; Singh, Reena; Varadharasu, Sivasankari; Dixit, Sanjukta; Sahoo, Debajani; and Biswal, Saudamini.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The present invention provides a matrix-type transdermal patch comprising olanzapine as an active pharmaceutical ingredient (102) in a range of 1% to 20% by weight, polymer matrix materials (104) in a range of 20% to 80% by weight, permeation enhancers (106) in a range of 5% to 40% by weight, adhesives (108) in a range of 10% to 50% by weight, stabilizers (110) in a range of 0.1% to 5% by weight, solubilizers (112) in a range of 0.5% to 10% by weight, plasticizers (114) in a range of 0.5% to 8% by weight, antioxidants (116) in a range of 0.01% to 2% by weight, and a backing layer (118) for skin application. The patch provides controlled olanzapine delivery over 24 to 72 hours while maintaining therapeutic plasma concentrations, bypassing first-pass metabolism, reducing gastrointestinal side effects, and improving patient compliance."
Disclaimer: Curated by HT Syndication.
